1. Department of Respiratory, Inflammation and Autoimmunity, AstraZeneca R&D Gothenburg, Mölndal, Sweden;
2. Department of Cardiovascular and Metabolic Diseases, AstraZeneca R&D Gothenburg, Mölndal, Sweden;
3. Department of Personalised HealthCare & Biomarkers, AstraZeneca R&D Gothenburg, Mölndal, Sweden;
4. Department of Drug Safety and Metabolism, AstraZeneca R&D Gothenburg, Mölndal, Sweden;
5. Blizard Institute, Barts and the London School of Medicine and Dentistry, QMUL, London, UK;
6. Department of Gastroenterology, IBD Center, Humanitas Research Hospital, Milan, Italy;
7. Digestive Disease Center K, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark